An association between alcohol and rectal cancer has been reported in the epidemiological literature. In this study we further explore the association by examining specific tumor markers with alcohol consumption as well as types of alcoholic beverages consumed.
A lcohol has been associated with increased risk of colorectal cancer, however, unresolved issues include the type of alcohol that influences risk, the amount and timing of alcohol consumed, and the impact of alcohol on specific colorectal cancer sites. 1 Some studies suggest that associations may be stronger for more distal or rectal cancer, whereas others show similar associations for both colon and rectal cancer. 2, 3 Some studies show stronger associations with beer or liquor and rectal cancer, whereas others report stronger associations for alcohol overall with rectal tumors rather than colon tumors. 1, 4, 5 Studies of colon cancer suggest that alcohol consumption could contribute to specific types of tumor mutations, with high levels of alcohol increasing the likelihood of a microsatellite unstable tumor. 6, 7 Unique associations between alcohol and types of alcoholic beverages consumed could contribute to specific tumor mutations. Long-term use of alcohol could contribute to DNA damage or epigenetic changes that cause the initiation of tumors, whereas more recent use could influence tumor promotion from events such as oxidative stress or from specific antioxidants. Thus, evaluation of both long-term alcohol use and more recent use could help define the association between alcohol intake and rectal cancer. Associations with specific types of alcoholic beverages also could indicate that nonalcohol components of the alcoholic beverages alter risk rather than the alcohol itself.
In this study, we evaluate consumption of total alcohol as well as alcoholic beverages, including wine, beer, and liquor over the 20 years preceding diagnosis and during the referent year (2 y before diagnosis) with specific epigenetic and genetic changes in rectal tumors. Data come from a population-based study of rectal cancer conducted in Northern California and Utah. We test the hypothesis that specific types of alcohol contribute to common epigenetic and genetic changes in rectal tumors.
METHODS
Participants in the study were from the Kaiser Permanente Medical Care Program of Northern California (KPMCP) and the state of Utah; study protocol and consent forms were approved by institutional review boards at the Kaiser Permanente Medical Care Program in Oakland, CA, and the University of Utah in Salt Lake City, UT. Cases with a first primary tumor in the rectosigmoid junction or rectum as determined by the Surveillance Epidemiology and End Results Cancer Registries in Northern California and Utah between May 1997 and May 2001 were identified. To be eligible for the study, participants had to be between 30 and 79 years of age at time of diagnosis, speak English, be mentally competent to complete the interview, have no previous colorectal cancer, 8 and not have known (as indicated on the pathology report) familial adenomatous polyposis, ulcerative colitis, or Crohn's disease. All eligible cases within the study time period and geographic area were recruited for the study.
Tumor block retrieval involved obtaining biopsy before treatment and paraffin-embedded tissue from the resection. In Utah, blocks were requested for all patients, with the exception of those who refused to release blocks. At the KPMCP, samples were retrieved from persons who signed a consent form at the time of interview or who had died after the interview. A total of 1495 rectal cancer cases were identified; of those identified, 239 people had not given consent to have the tissue released (15.9%), and an additional 234 cases did not have adequate tumor tissue to obtain DNA. Tumor DNA was extracted from 81.4% of all rectal cancer cases identified, of which 750 cases had interview data. Controls were randomly selected from membership lists at KPMCP and, in Utah, from social security lists and driver's license lists (for participants less than 65 y); 1205 controls (68.8% of those selected) participated.
Genetic Analysis
Tumor DNA obtained from paraffin-embedded tissue was characterized by the genetic profile that included sequence data for exons 5 through 8, the mutation hotspot exons of the TP53 gene; sequence data for KRAS2 codons 12 and 13; and 5 CIMP markers, methylated in tumor (MINT)1, MINT2, MINT31, CDKN2A (p16), and MLH1. 6, 9, 10 These tumor markers were selected because of their frequent alterations in colorectal tumors. CIMP-positive tumors were defined as having 2 or more of 5 markers methylated. At this time, there is no "consensus" as to the appropriate CIMP panel or method of detection. However, we have used our panel to demonstrate significant relationships between CIMP and numerous variables, including cigarette smoking and the BRAF V600E mutation, which were independent of microsatellite instability. 11, 12 This work has helped to support the legitimacy of the CIMP concept. 13 For a small subset of cases, approximately 35, we evaluated both biopsy before treatment and resection after treatment and did not identify differences in CIMP status as a result of treatment modality.
Diet and Lifestyle Data
Trained and certified interviewers collected diet and lifestyle data as previously outlined. 14, 15 In brief, interviews were conducted in the participant's home or workplace with use of a laptop computer. All interviewers were thoroughly trained and all interviews were audio-taped for quality control purposes. 14 The referent year for the study was the calendar year approximately 2 years before the date of diagnosis (cases) or selection (controls). Information was collected on demographic factors such as age, gender, and study center; physical activity; body size; cigarette smoking history; use of aspirin and nonsteroidal anti-inflammatory drugs; family history of colorectal cancer in first-degree relatives; medical and reproductive history including use of hormone replacement therapy.
Dietary intake was ascertained by use of an adaptation of the CARDIA (Coronary Artery Risk Development in Adults Study) diet history. [15] [16] [17] Participants were asked to recall foods eaten, the frequency at which they were eaten, serving size, and fats, if they were added in the preparation. Recent alcoholic beverage intake was obtained for the referent year as part of the diet history questionnaire. We asked about specific types of alcohol consumed and the usual amount consumed for the weekend days (Friday, Saturday, and Sunday) and weekdays (Monday through Thursday). In addition, as part of the health and lifestyle questionnaire, we obtained alcoholic beverage consumption patterns by asking participants to report their usual consumption patterns of liquor, wine, and beer for 10 and 20 years before to get a better indication of the patterns of long-term consumption of alcoholic beverages. Long-term consumption of alcohol was based on the average intake reported for those 2 time periods.
Statistical Analysis
We assessed total alcohol reported, alcohol from liquor, wine, and beer during the referent year taken from the diet history questionnaire, and long-term alcohol use as determined in the health and lifestyle history questionnaire. Alcohol consumption levels were based on consumption patterns in the population and literature reports of level of consumption and were classified as none, moderate (Ͼ0 to Ͻ20 g per day for men, Ͼ0 to Ͻ10 g per day for women), and high (Ն20 g per day for men, Ն10 g per day for women). We assessed specific types of alcoholic beverage to help determine whether other components in alcoholic beverages contributed to risk. Cutpoints were based on the distribution of alcohol consumption; cutpoints used for alcohol consumption for men were 0 and 7 g of alcohol from beer, and for women, 0 and 2 g of alcohol from beer; for wine, cutpoints used for alcohol consumption for men were 0 and 3 g of alcohol from wine, and for women, 0 and 5 g of alcohol from wine; and for hard liquor, cutpoints used for alcohol consumption for men were 0 and 10 g of alcohol from hard liquor, and for women, 0 and 5 g of alcohol from hard liquor. For recent alcohol consumption during the referent year we had more information on types of alcoholic beverage consumed and were able to evaluate consumption of red and white wine separately. In addition to looking at associations based on grams of alcohol, we assessed associations based on drinks of alcoholic beverage per day. Associations were evaluated with a referent group of nondrinkers as well as nondrinkers of a specific type of alcohol; in general, associations were the same for both referent groups. We assessed associations for long-term use of 10 and 20 years duration, as well as during the more recent referent year. In addition, we assessed alcohol consumption based on the combination of the long-term and recent use variables. The long-term alcohol consumption in individuals less than 40 years of age was weighted by their reported intake 10 years earlier.
All statistical analyses were performed by use of SAS version 9.1 (SAS Institute, Cary, NC). Tumors were defined by specific mutations detected as any TP53 vs no TP53 mutation, any KRAS2 mutations vs no KRAS2 mutation, or CIMP positive vs CIMP negative. For TP53 and KRAS2 mutations, we also examined transversion and transition mutations since specific types of mutations were assessed because other studies had shown that specific mutations had etiologic associations. 10, 18 To compare specific types of mutations with controls while adjusting for the other tumor mutations simultaneously, a generalized estimating equation with a multinomial outcome was used because case subjects could contribute from 1 to 3 outcome observations depending on how many tumor mutations (CIMP, KRAS2, TP53) were present in a tumor. 19 The generalized estimating equation accounted for correlation introduced by including subjects multiple times and was implemented by use of the GENMOD procedure as described by Kuss et al. 20 All models were adjusted for age at diagnosis or selection and gender along with other factors that have been shown to be related to colon cancer, including body mass index in kg/m 2 , long-term vigorous physical activity, pack-years of cigarettes smoked, dietary calcium, and total energy intake. We assessed associations with consumption of specific alcoholic beverages in models with and without adjustment for total grams of longterm and referent year alcohol intake used as a continuous variable. P for trend was assessed by using ordered categories of variables and comparing the likelihood ratio of a model with the variable to the likelihood ratio of a model without the variable using the 2 test with one degree of freedom. To examine the association between components of the alcoholic beverages, we evaluated the associations with the beverages with and without adjusting for grams of alcohol intake for long-term and recent alcohol consumption during the referent year ( Table 2 ). Associations for beer and wine became slightly stronger after adjusting for alcohol intake. Beer consumed during the referent period significantly increased risk of having a TP53 tumor mutation; red wine was nonsignificantly inversely associated with TP53 mutation, whereas white wine was not associated with TP53 risk. We did not observe any effect modification by pack-years of cigarettes smoked.
RESULTS
Long-term consumption of liquor increased the odds of having a CIMP-positive rectal tumor (Table 3) after adjusting for alcohol. There were no significant associations with consumption of alcohol in the past from either beer or wine for any types of mutations.
Evaluation of specific types of TP53 mutations and alcohol showed that both long-term beer consumption and recent beer consumption were associated most strongly with transversion mutations ( Table 4 ). Evaluation of common TP53 point mutation (data not shown in table) showed that long-term liquor consumption increased the odds of having a mutation at codon 248 (OR, 4.97; 95% CI 1.28,19.38 for high vs no consumption), whereas high levels of recent beer consumption increased the odds of 
DISCUSSION
A major consideration of studies of alcoholic beverages is determining whether associations are due to the alcoholic content of the beverage or other nonalcoholic components of these drinks. Our results suggest that alcohol may contribute to an increased likelihood of a CIMP-positive tumor, whereas the nonalcoholic components of wine and beer may influence TP53 mutations in rectal tumors. Further assessment of specific types of TP53 mutations showed that beer was more likely to influence transversion mutations in the TP53 gene. Associations with beer were stronger after adjusting for grams of alcohol, further suggesting that nonalcohol components of beverages contribute to rectal cancer risk. The literature on the association between alcohol and rectal cancer is extensive, but inconclusive. 1, 4, [21] [22] [23] [24] [25] Consistent with other studies, we observed few significant findings with KRAS2 mutations. 5 In these data we saw significant associations between total grams of alcohol consumed and CIMP-positive rectal tumors. However, we were unable to evaluate associations with microsatellite instability (MSI) because of the few rectal tumors with MSI. 26 We have reported that CIMP-positive colon tumors were not associated with alcohol. 6, 7 Liquor, the alcoholic beverage with the most concentrated alcohol content, was associated with CIMP-positive rectal tumors. Others have shown that alcohol is associated with methylated head and neck tumors. 27 Given the association with total alcohol and liquor, the most concentrated source of alcohol, we interpret this as an indication that alcohol itself, rather than some nonalcohol component in alcoholic beverages, is associated with CIMP-positive rectal tumors.
The pattern of risk associated with beer and wine suggests that a nonalcoholic component of these beverages may be influencing risk, especially when the association between beer and wine and TP53-mutated tumors appears to be stronger after adjusting for the effects of grams of alcohol consumed. Furthermore, the trend toward an association of decreased risk with wine appears to be restricted to red wine, which contains polyphenols that have antioxidant properties. 28, 29 Studies have shown that TP53 mutations are associated with oxidative stress 30 ; thus, it is reasonable to hypothesize a protective effect by flavonoidcontaining beverages. Findings for liquor were similar to those observed for red wine, suggesting either a similar mechanism or a chance finding for both wine and liquor consumption and TP53 mutations Epidemiological studies have reported direct association between beer consumption and rectal cancer with associations varying by amount and time of consumption. 4, 23, 25 Although the association between beer consumption and rectal tumors overall was null in our study, we observed a significant association between beer and TP53 mutations. TP53 mutations are the most common mutation in a number of cancers and are one of the most commonly detected mutations in rectal tumors. It is noteworthy that we also observed that transversion mutations were associated with the greatest risk from recent consumption of beer and alcohol; there was also an indication that specific point mutations may be influenced by beer intake. Point mutation hotspots within TP53 are in the evolutionarily conserved areas of the gene. 31 An arginine residue at codon 248 in the L3 loop of the core domain of the gene is thought to play a critical role in DNA binding; an arginine at codon 175 is located in the L2 loop in the vicinity of the zinc binding site; a glycine at codon 245, also in the L3 loop, allows the L3 loop to assume unique conformations. 32 Furthermore, mutations in specific sites have been linked with specific exposures that alter cancer risk. For instance, polycyclic aromatic hydrocarbons and benzo[a]pyrene have been associated with GϾT transversions and TP53 mutations at codons 157, 248, and 273 31, 33 ; aflatoxin has been associated with mutations at codon 249. 31 Studies have shown that the guanine base (G) is highly susceptible to oxidative stress because it has the lowest oxidation potential of the 4 DNA nucleotide bases; thus, transversion mutations involving a G:CϾT:A change occur more frequently under conditions of oxidative stress. 34, 35 Nitric oxide can cause DNA damage; it has been shown to induce TP53 accumulation and posttranslational modification 30, 36 that can lead to the selective expansion of mutated TP53 cells. 30 Studies have shown that nitric oxide, in an inflammatory condition such as ulcerative colitis, can increase the frequency of TP53 mutations. 37 Our data suggest that some nonalcohol components of beer may contribute to TP53 risk, with the greatest risk for more recent beer consumption during the referent year. It is possible that some component of beer contributes to oxidative stress resulting in the observed increased risk of TP53 mutations, especially transversions. Beer contains isohumulones, the bitter acids from hops, 38 which have many chemo-preventive properties. Isohumulones have been shown to reduce insulin resistance, activate the peroxisome proliferator receptor ␣, and inhibit angiogenesis by suppressing cyclooxygenase-2. 38 Hops also have DISEASES OF THE COLON & RECTUM VOLUME 53: 8 (2010) been shown to exhibit estrogen-like activities. 39 Studies conducted in rats further suggest that the chemo-preventive constituents of beer protect against heterocyclic amine-induced mutagenesis. 40, 41 Although our results do not support a chemo-preventive role for beer, as much of the literature might suggest, our observed associations of increased risk are consistent with other epidemiological research findings. 1, 4, 5, 25, 42 This investigation is one of the largest populationbased studies of rectal tumor mutations reported to date; however, it is not without limitations. Other than the reports cited above, other reports on alcohol and risk factors for rectal tumor mutations have not been published. Although the numbers of cases and controls were large, we were still limited in our ability to test associations for mutations or epigenetic changes that are uncommon in rectal tumors, such as CIMP, MSI, or specific point mutations. Although we were able to detect significant associations with total long-term alcohol consumption and CIMP-positive tumors, other types of alcoholic beverages that may have had a smaller effect could have been missed because of lack of power. There is a potential error in subject recall of alcohol consumption, especially when considering details of consumption patterns. We have attempted to evaluate the impact of recalling alcohol in the setting in which the study took place, including the potential for differential recall in the presence of a third party. 43 In addition, we sequenced only the mutation hot spots of the TP53 and KRAS2 genes, and therefore, some samples may have been misclassified as not having a TP53 or KRAS2 mutation. To thoroughly test our study hypothesis, many comparisons were made. It is possible that associations detected were the result of chance.
CONCLUSIONS
Our data suggest that not all alcoholic beverages uniformly contribute to epigenetic and genetic changes in rectal tumors. Furthermore, it appears that the nonalcoholic components of beer and wine may alter the risk of developing a TP53 mutation. Replication of these findings is needed. Our evaluation of alcoholic beverages as they relate to specific types of rectal mutations provides additional insight into potential biological mechanisms, as well as an explanation for some of the differences reported between alcohol and rectal cancer in the literature. These findings re-enforce the previous work that shows that alcohol consumption could influence the risk of rectal cancer.
